Prisinformation från TradingView

Bolagspresentation:

Nyhetsflöde Innofactor

Related articles:
4/24/2024 8:43:49 AM - Innofactor: Holding firm in challenging market - Evli - Innofactor’s Q1 was in line with expectations. We continued to expect modest growth in sales and EBITDA while eyeing improvements in new sales.
4/23/2024 7:49:24 AM - Innofactor: In line with our expectations - Evli - Innofactor’s Q1 results were well in line with our expectations. Net sales were up ~5% y/y to EUR 21.2m (Evli EUR 21.0m) while EBITDA amounted to EUR 2.6m (Evli EUR 2.6m). Guidance for 2024 reiterated: Innofactor’s net sales and EBITDA are expected to increase compared with 2023.
2/9/2024 8:14:13 AM - Innofactor: Growth pace uncertainty - Evli - Innofactor’s Q4 was in line with expectations. Continued uncertainty reduces visibility going into 2024 but good potential remains. We adjust our TP to EUR 1.5 (1.4), BUY-rating intact.
2/8/2024 8:02:53 AM - Innofactor: Year-end quite as expected - Evli - Innofactor’s Q4 results were rather good and quite as expected. Net sales were up ~7% y/y to EUR 21.9m (Evli EUR 22.1m). EBITDA was in line with our expectations at EUR 2.9m (Evli EUR 2.9m). Guidance for 2024: Innofactor’s net sales and EBITDA are expected to increase compared with 2023. Dividend proposal EUR 0.07 per share (Evli EUR 0.07)
10/25/2023 7:39:54 AM - Innofactor: Good going, at least for now - Evli - Innofactor posted good Q3 results, in line with our estimates. The market situation continues to be challenging and remains the key concern going forward. We retain our BUY-rating with a target price of EUR 1.4 (1.5).
10/24/2023 6:49:21 AM - Innofactor: Good performance despite headwinds - Evli - Innofactor’s Q3 results were good and quite as expected despite market headwinds. Net sales were organically up 8% y/y to EUR 18.0m (Evli EUR 18.1m). EBITDA was slightly above expectations at EUR 2.0m (Evli EUR 1.8m). Guidance reiterated, Innofactor’s net sales and EBITDA in 2023 are expected to increase compared with 2022.
7/21/2023 7:54:24 AM - Innofactor: Ups and downs - Evli - Innofactor saw some challenges in Q2 but still reported rather decent results. Increased price competition remains a short-term threat, but financially, we expect improvements towards the end of the year.
7/20/2023 6:53:17 AM - Innofactor: Some challenges but still quite good - Evli - Innofactor’s Q2 saw continued good growth, better than anticipated, up 18.6% y/y to EUR 20.1m (Evli EUR 19.4m). EBITDA was below expectations at EUR 1.8m (Evli EUR 2.3m), with the EBITDA-margin improving slightly y/y. Guidance reiterated, Innofactor’s net sales and EBITDA in 2023 are expected to increase compared with 2022.
4/27/2023 5:22:25 AM - Innofactor: Operational stability being achieved - Evli - Innofactor’s Q1 results were good and beat our expectations. The outlook remains quite favourable, and we do not expect performance during the remainder of 2023 to significantly improve from the good performance in Q1.
4/25/2023 7:37:09 AM - Innofactor: Solid growth pace continues - Evli - Innofactor’s Q1 results were good and surpassed our expectations. Net sales grew 19.2% y/y to EUR 20.2m (Evli EUR 18.3m). EBITDA amounted to EUR 2.5m (Evli EUR 2.2m). Guidance reiterated, Innofactor’s net sales and EBITDA in 2023 are expected to increase compared with 2022.
2/10/2023 7:20:35 AM - Innofactor: Starting to prove its worth - Evli Research - Good figures posted in Q4
2/9/2023 11:46:45 AM - Innofactor: Nice finish to the year - Evli - Innofactor’s Q4 results were in line with expectations. Net sales grew 17.1% y/y to EUR 20.5m (Evli EUR 20.5m). EBIT amounted to EUR 1.8m (Evli EUR 1.9m). Innofactor’s net sales and EBITDA in 2023 are expected to increase compared with 2022. Dividend proposal EUR 0.06 per share (Evli EUR 0.06).
10/26/2022 7:55:43 AM - Innofactor: Showing much needed improvement - Evli - Innofactor showed promising progress in Q3, boding well for 2023, and now needs to provide further signs of sustained performance given recent challenges. We retain our target price of EUR 1.25 and BUY-rating intact.
10/25/2022 7:53:11 AM - Innofactor: Posted solid growth figures - Evli - Innofactor’s Q3 results were better than expected. Net sales turned to a clear growth of 21.5% y/y to EUR 16.7m (Evli EUR 14.9m) aided by improved invoicing rates after the more challenging first half of 2022. Q3 EBIT of EUR 1.0m was in line with our estimates (Evli EUR 1.1m).
7/22/2022 7:35:24 AM - Innofactor: Need to start delivering - Evli - Innofactor’s Q2 results were weaker than anticipated to a weakened billing rate and individual project delivery challenges. Improvement is needed during H2 to achieve the FY ‘22 guidance. Near-term operational capabilities are still of some concern, but the potential is still quite solid. We adjust our TP to EUR 1.25 (1.6), BUY-rating intact.
7/21/2022 7:53:21 AM - Innofactor: Subpar performance - Evli - Innofactor’s Q2 results were weaker than expected. Net sales declined 2% y/y to EUR 16.9m (Evli EUR 17.7m) due to a weakened invoicing ratio and individual project delivery challenges. Q2 EBIT of EUR 0.7m was also clearly weaker than in the comparison period and our estimates (Evli EUR 1.4m).
4/27/2022 5:42:32 AM - Innofactor: Growth progress still challenging - Evli - Innofactor’s revenue development in Q1 was weakened by increased absences due to sickness, while profitability climbed back to rather healthy levels. Signs of clear pick-up in growth remain limited but potential exists.
4/26/2022 7:37:59 AM - Innofactor: Profitability back on track - Evli - Innofactor’s Q1 results were slightly better than expected. Although net sales of EUR 17.0m were below expectations (Evli EUR 17.8m), with sales having decreased in Finland and Sweden due to increased sick leaves, profitability was at good levels after some challenges during H2/21, with EBITDA amounting to EUR 2.0m (Evli EUR 1.8m).
2/18/2022 8:15:07 AM - Innofactor: Moving on from recent challenges - Evli - Innofactor’s Q4 fell well short of our expectations as the company saw challenges relating to organizational changes and employee turnover. We have lowered our 2022 estimates and our TP to EUR 1.6 (2.1), BUY-rating intact.
2/17/2022 9:54:27 AM - Innofactor: A softer end to the year - Evli - Innofactor’s Q4 results were below our expectations. Net sales amounted to EUR 17.5m (Evli EUR 18.6m), while EBITDA amounted to EUR 1.7m (Evli EUR 2.6m). Net sales in 2022 are expected to increase from 2021 and EBITDA from comparable 2021 EBITDA of EUR 7.5m. Dividend proposal EUR 0.08 per share (Evli EUR 0.06).
10/27/2021 7:09:48 AM - Innofactor: Some challenges with growth - Evli - Innofactor’s Q3 profitability remained at good levels but growth was not quite as good as expected due to organizational restructuring causing a sales dip in Finland. Recruitments pose some concerns for future growth but all in all the Q3 report did not change much.
10/26/2021 6:57:46 AM - Innofactor: No major surprises - Evli - Innofactor’s Q3 results were close to our expectations. Net sales amounted to EUR 13.7m (Evli EUR 14.5m), while EBITDA amounted to EUR 1.7m (Evli EUR 1.8m). The order backlog growth halted due to a lack of new significant orders but was still up 24% y/y at EUR 72.0m.
7/23/2021 6:06:37 AM - Innofactor: Continued steady performance - Evli Research - Q2 well in line with our expectations
7/22/2021 6:39:31 AM - Innofactor: Figures as expected - Evli Research - Innofactor’s Q2 results were as expected. Net sales amounted to EUR 17.3m (Evli EUR 17.3m), while EBITDA amounted to EUR 2.1m (Evli EUR 2.2m). The order backlog continued to grow well, up 28% y/y to EUR 72.7m.
4/28/2021 6:54:29 AM - Innofactor: Good start to the year - Evli Research - Q1 well in line with our estimates
4/27/2021 6:51:15 AM - Innofactor: Well in line with expectations - Evli - Innofactor’s Q1 results were in line with our expectations. Net sales amounted to EUR 17.8m (Evli EUR 17.9m), while EBITDA amounted to EUR 4.7m (Evli EUR 4.8m). EBITDA included a one-off of approx. EUR 2.6m related to the Prime business divestment.
4/23/2021 7:50:45 AM - Innofactor: Divestment secures a solid start - Evli Research - Q1 boosted by divestment one-off
2/18/2021 7:32:46 AM - Innofactor: Write-down burdened profitability - Evli Research - Innofactor’s Q4 results were on an adj. basis above our expectations. Net sales amounted to EUR 18.3m (Evli EUR 17.6m), while EBITDA amounted to EUR 1.6m (Evli EUR 2.1m). EBITDA included one-offs of EUR 1.0m and adj. figures were better than expected. Dividend proposal EUR 0.04 per share (Evli EUR 0.03). Net sales and EBITDA in 2021 are estimated to increase compared to 2020.
10/28/2020 6:55:50 AM - Innofactor: Eager to see what the future holds - Evli Research - Good results in the by COVID-19 impact weakened quarter
8/4/2020 7:43:30 AM - Innofactor: On track despite the pandemic - Evli Research - Delivered a positive earnings surprise
5/6/2020 8:04:24 AM - Innofactor: Right on track – Evli Research - Innofactor: Right on track – Evli Research